Gilead Sciences, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2025: USD 2.77 B

Gilead Sciences, Inc. Depreciation And Amortization is USD 2.77 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 1.09% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • Gilead Sciences, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 2.74 B, a 23.67% change year over year.
  • Gilead Sciences, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 2.22 B, a 5.52% change year over year.
  • Gilead Sciences, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 2.10 B, a 31.05% change year over year.
  • Gilead Sciences, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 1.60 B, a 15.06% change year over year.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased